References
- SantMAllemaniCSantaquilaniMEUROCARE working group. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentaryEur J Cancer200945693199119171476
- SmithMASeibelNLAltekruseSFOutcomes for children and adolescents with cancer: challenges for the twenty-first centuryJ Clin Oncol201028152625263420404250
- HayekERSpeakmanERehmusEAcute doxorubicin cardiac toxicityN Engl J Med2005352232456245715944435
- MinottiGMennaPSalvatorelliEAnthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiac toxicityPharmacol Rev200456218522915169927
- ChenYJungsuwadeePVoreMCollateral damage in cancer chemotherapy: oxidative stress in non targeted tissuesMol Interv20077314715617609521
- GoormaghtighEHuartPPraetMStructure of the adriamycin–cardiolipin complex role in mitochondrial toxicityBiophys Chem1990352–32472572204444
- MantawyEMEl-BaklyWMEsmatAChrysin alleviates acute doxorubicin cardiac toxicity in rats via suppression of oxidative stress, inflammation and apoptosisEur J Pharmacol201472810711824509133
- BarbaricMMiskovicKBojicMChemical composition of the ethanolic propolis extracts and its effect on HeLa cellsJ Ethnopharmacol2011135377277821515353
- ChenXCZhuYGZhuLAGinsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stressEur J Pharmacol200347311712877931
- GuBNakamichiNZhangWSPossible protection by notoginsenoside R1 against glutamate neurotoxicity mediated by N-methyl-D-aspartate receptors composed of an NR1/NR2B subunit assemblyJ Neurosci Res20098792145215619224577
- LeeJSSongJHSohnNWInhibitory effects of ginsenoside Rb1 on neuroinflammation following systemic lipopolysaccharide treatment in micePhytother Res20122791270127623042638
- LiangWGeSYangLGinsenosides Rb1 and Rg1 promote proliferation and expression of neurotrophic factors in primary Schwann cell culturesBrain Res20101357192520682297
- LinWMZhangYMMoldzioRGinsenoside Rb attenuates neuroinflammation of dopaminergic cells in cultureJ Neural Transm Suppl20077210511217982883
- WangYFengYFuQPanax notoginsenoside Rb1 ameliorates Alzheimer’s disease by regulating brain-derived neurtotrophic factor and downregulating Tau protein expressionExp Ther Med20136382683024137274
- TamWYChookPQiaoMThe efficacy and tolerability of adjunctive alternative herbal medicine (Salvia miltiorrhiza and Pueraria lobata) on vascular function and structure in coronary patientsJ Altern Complement Med200915441542119388864
- SievekingDPWooKSFungKPChinese herbs Danshen and Gegen modulate key early atherogenic events in vitroInt J Cardiol20051051404516207543
- WuLQiaoHLiYProtective roles of puerarin and Danshensu on acute ischemic myocardial injury in ratsPhytomedicine2007141065265817870452
- WuCHLaiXJChengCJNovel applications of digital holographic microscopy in therapeutic evaluation of Chinese herbal medicinesAppl Opt201453G192G19725322130
- WangSELinCLHsuCHTreatment of a herbal formula B401 enhances neuroprotection and angiogenesis in the R6/2 mouse model of Huntington’s diseaseDrug Des Dev Ther20159887900
- ChienCTFanSCLinSCGlucagon-like peptide-1 receptor agonist activation ameliorates venous thrombosis-induced arteriovenous fistula failure in chronic kidney diseaseThromb Haemost201411251051106425030617
- FouadAAYacoubiMT2011. Mechanisms underlying the protective effect of eugenol in rats with acute doxorubicin cardiac toxicityArch Pharm Res201134582182821656368
- SimunekTŠterbaMPopelovaOAnthracycline-induced cardiac toxicity: overview of studies examining the roles of oxidative stress and free cellular ironPharmacol Rep200961115417119307704
- DoroshowJHLockerGYMyersCEEnzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicinJ Clin Invest19806511281357350193
- ChaiswingLColeMPSt ClairDKOxidative damage precedes nitrative damage in adriamycin-induced cardiac mitochondrial injuryToxicol Pathol200432553654715605432
- HouGDickRAbramsGDTetrathiomolybdate protects against cardiac damage by doxorubicin in miceJ Lab Clin Med2005146529930316242529
- Abd El-AzizTAMohamedRHPashaHFCatechin protects against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated ratsClin Exp Med201212423324022080234
- KalayNBasarEOzdogruIProtective effects of carvedilol against anthracycline-induced cardiomyopathyJ Am Coll Cardiol200648112258226217161256
- ReeveJLSzegezdiELogueSEDistinct mechanisms of cardiomyocyte apoptosis induced by doxorubicin and hypoxia converge on mitochondria and are inhibited by Bcl-xLJ Cell Mol Med200711350952017635642
- KunisadaKToneENegoroSBcl-xl reduces doxorubicin induced myocardial damage but fails to control cardiac gene down-regulationCardiovasc Res200253493694311922903
- DesagherSMartinouJCMitochondria as the central control point of apoptosisTrends Cell Biol200010936937710932094
- MachadoNGAlvesMGCarvalhoRAMitochondrial involvement in cardiac apoptosis during ischemia and reperfusion: can we close the box?Cardiovasc Toxicol20099421122719855945
- GreenPSLeeuwenburghCMitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosisBiochim Biophys Acta2002158819410112379319
- NicholsonDWThornberryNAApoptosis. Life and death decisionsScience2003299560421421512522239
- MantawyEMEl-BaklyWMEsmatAChrysin alleviates acute doxorubicin cardiac toxicity in rats via suppression of oxidative stress, inflammation and apoptosisEur J Pharmacol201472810711824509133
- SultanaSVermaKKhanRNephroprotective efficacy of chrysin against cisplatin-induced toxicity via attenuation of oxidative stressJ Pharm Pharmacol201264687288122571266
- MachadoNGAlvesMGCarvalhoRAMitochondrial involvement in cardiac apoptosis during ischemia and reperfusion: can we close the box?Cardiovasc Toxicol20099421122719855945